New Ebola drug 100% effective in monkey trial

The newly created Ebola drug known as ZMapp was successful in saving all of the monkeys from dying from Ebola in a trial, according to research published in Nature.

ZMapp was able to rescue 100 percent of rhesus macaques, even when treatment was initiated up to five days after infection with the disease in advanced stages — notable findings since there is no known cure for Ebola.

"The evidence presented here suggests that ZMapp offers the best option of the experimental therapeutics currently in development for treating [Ebola-infected] patients," the researchers wrote. "We hope that initial safety testing in humans will be undertaken soon, preferably within the next few months, to enable the compassionate use of ZMapp as soon as possible."

ZMapp has been used to treat human Ebola patients during what is the worst Ebola outbreak in history: Seven patients globally have received the medication. However, two of those seven patients later died from Ebola, according to BBC.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars